Laura Lagares‐Tena

558 total citations
19 papers, 428 citations indexed

About

Laura Lagares‐Tena is a scholar working on Molecular Biology, Cell Biology and Surgery. According to data from OpenAlex, Laura Lagares‐Tena has authored 19 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cell Biology and 5 papers in Surgery. Recurrent topics in Laura Lagares‐Tena's work include Caveolin-1 and cellular processes (5 papers), Pelvic floor disorders treatments (4 papers) and Anorectal Disease Treatments and Outcomes (3 papers). Laura Lagares‐Tena is often cited by papers focused on Caveolin-1 and cellular processes (5 papers), Pelvic floor disorders treatments (4 papers) and Anorectal Disease Treatments and Outcomes (3 papers). Laura Lagares‐Tena collaborates with scholars based in Spain, United States and Australia. Laura Lagares‐Tena's co-authors include Òscar M. Tirado, Silvia Mateo‐Lozano, Miguel Sáinz‐Jaspeado, Xavier García del Muro, Cristina Muñoz‐Pinedo, Juan Martín-Liberal, Nadia El Mjiyad, Silvia Ramírez‐Peinado, Alfredo Caro‐Maldonado and Roser López‐Alemany and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Cancer.

In The Last Decade

Laura Lagares‐Tena

19 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Lagares‐Tena Spain 10 242 134 109 91 83 19 428
Vivianne W. Ding United States 8 462 1.9× 81 0.6× 100 0.9× 42 0.5× 43 0.5× 11 610
Guolin Tan China 8 343 1.4× 51 0.4× 93 0.9× 105 1.2× 58 0.7× 16 432
Takaharu Kamo Japan 11 229 0.9× 59 0.4× 152 1.4× 76 0.8× 83 1.0× 16 466
Julien H. Dey Switzerland 7 312 1.3× 46 0.3× 124 1.1× 104 1.1× 35 0.4× 7 446
Yasuyuki Minakawa Japan 12 293 1.2× 75 0.6× 111 1.0× 123 1.4× 21 0.3× 16 443
Frederick Kweh United States 6 260 1.1× 147 1.1× 126 1.2× 64 0.7× 16 0.2× 7 522
Tracey Amanda Martin United Kingdom 11 265 1.1× 86 0.6× 168 1.5× 111 1.2× 26 0.3× 15 478
Ran Qi China 10 302 1.2× 63 0.5× 79 0.7× 170 1.9× 29 0.3× 17 457
Paulo Rodrigues Spain 11 226 0.9× 42 0.3× 138 1.3× 104 1.1× 50 0.6× 16 378
Yasuyo Chochi Japan 10 227 0.9× 81 0.6× 80 0.7× 80 0.9× 81 1.0× 14 437

Countries citing papers authored by Laura Lagares‐Tena

Since Specialization
Citations

This map shows the geographic impact of Laura Lagares‐Tena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Lagares‐Tena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Lagares‐Tena more than expected).

Fields of papers citing papers by Laura Lagares‐Tena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Lagares‐Tena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Lagares‐Tena. The network helps show where Laura Lagares‐Tena may publish in the future.

Co-authorship network of co-authors of Laura Lagares‐Tena

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Lagares‐Tena. A scholar is included among the top collaborators of Laura Lagares‐Tena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Lagares‐Tena. Laura Lagares‐Tena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Muñoz-Duyos, Arantxa, et al.. (2021). Teleconsultation in a coloproctology unit during the COVID-19 pandemic. Preliminary results. Cirugía Española (English Edition). 99(5). 361–367. 2 indexed citations
3.
Muñoz-Duyos, Arantxa, et al.. (2020). Teleconsulta en una unidad de coloproctología durante la pandemia de COVID-19. Resultados preliminares. Cirugía Española. 99(5). 361–367. 3 indexed citations
4.
Lagares‐Tena, Laura, et al.. (2018). Sacral neuromodulation in patients with congenital faecal incontinence. Special issues and review of the literature. Techniques in Coloproctology. 22(2). 89–95. 6 indexed citations
5.
López‐Alemany, Roser, David Herrero‐Martín, Laura Lagares‐Tena, et al.. (2018). EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma. International Journal of Cancer. 143(5). 1188–1201. 46 indexed citations
6.
Muñoz-Duyos, Arantxa, et al.. (2017). Treatment of chronic anal fissure with sacral neuromodulation: a pilot study. Techniques in Coloproctology. 21(9). 761–762. 3 indexed citations
7.
Muñoz-Duyos, Arantxa, et al.. (2017). Circuito de alta resolución en el diagnóstico de la incontinencia fecal. Satisfacción de los pacientes. Cirugía Española. 95(5). 276–282. 1 indexed citations
8.
Lagares‐Tena, Laura & Arantxa Muñoz-Duyos. (2017). Use of a new plasma scalpel during pulse generator implant and replacement in neuromodulation. Cogent Medicine. 4(1). 1353248–1353248. 1 indexed citations
9.
Lagares‐Tena, Laura, Roser López‐Alemany, Miguel Sáinz‐Jaspeado, et al.. (2016). Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway. Oncotarget. 7(35). 56889–56903. 42 indexed citations
10.
Rello‐Varona, Santiago, et al.. (2015). The Importance of Being Dead: Cell Death Mechanisms Assessment in Anti-Sarcoma Therapy. Frontiers in Oncology. 5. 82–82. 9 indexed citations
11.
Martín-Liberal, Juan, Laura Lagares‐Tena, & James Larkin. (2014). Prospects for MEK inhibitors for treating cancer. Expert Opinion on Drug Safety. 13(4). 483–495. 13 indexed citations
12.
Rello‐Varona, Santiago, David Herrero‐Martín, Miguel Sáinz‐Jaspeado, et al.. (2014). Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth. Oncotarget. 5(20). 9744–9755. 20 indexed citations
13.
Sáinz‐Jaspeado, Miguel, Laura Lagares‐Tena, Silvia Mateo‐Lozano, et al.. (2013). EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1. PLoS ONE. 8(8). e71449–e71449. 40 indexed citations
14.
Sáinz‐Jaspeado, Miguel, Laura Lagares‐Tena, Silvia Mateo‐Lozano, et al.. (2013). Abstract 3827: Caveolin-1 acts as a tumor suppressor promoting muscular differentiation in alveolar rhabdomyosarcomas.. Cancer Research. 73(8_Supplement). 3827–3827. 1 indexed citations
15.
Lagares‐Tena, Laura, et al.. (2012). Targeted Therapies in Sarcomas: Challenging the Challenge. Sarcoma. 2012. 1–13. 23 indexed citations
16.
Ramírez‐Peinado, Silvia, Laura Lagares‐Tena, Nadia El Mjiyad, et al.. (2011). 2-Deoxyglucose Induces Noxa-Dependent Apoptosis in Alveolar Rhabdomyosarcoma. Cancer Research. 71(21). 6796–6806. 78 indexed citations
17.
Sáinz‐Jaspeado, Miguel, Juan Martín-Liberal, Laura Lagares‐Tena, et al.. (2011). Caveolin-1 in sarcomas: friend or foe?. Oncotarget. 2(4). 305–312. 37 indexed citations
18.
Sáinz‐Jaspeado, Miguel, Laura Lagares‐Tena, Fariba Navid, et al.. (2010). Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize. Molecular Cancer Research. 8(11). 1489–1500. 46 indexed citations
19.
Dopeso, Higinio, Silvia Mateo‐Lozano, Rocco Mazzolini, et al.. (2009). The Receptor Tyrosine Kinase EPHB4 Has Tumor Suppressor Activities in Intestinal Tumorigenesis. Cancer Research. 69(18). 7430–7438. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026